Veracyte (VCYT) Tops Q2 EPS by 33c, provides guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Veracyte, Inc (VCYT) PT Lowered to $28 at Morgan Stanley
August 8, 2025 2:49 PM EDTMorgan Stanley analyst Tejas Savant lowered the price target on Veracyte, Inc (NASDAQ: VCYT) to $28.00 (from $29.00) while maintaining a Underweight rating.
The analyst comments "Solid 2Q beat on continued Decipher/Afirma momentum leading to '25 guidance raise; total company guidance now initiated following Veracyte SAS... More
